Effects of Capparis pickle on blood lipid

Not Applicable

Recruiting

• Conditions: Hypercholesterolemia.; Pure hypercholesterolemia

• Registration Number: IRCT2017032827532N1
• Lead Sponsor: Vice chancellor for research, Shahed University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 60

Inclusion Criteria

Hyperlipidemia (LDL= 100 based on Framingham criteria), sex: male, age 40 to 60 years.
Exclusion criteria: Hyperlipidemia during treatment; pregnancy and lactation; CHD patient; BP = 140/90; Coagulopathies; thyroid disease; Having a particular diet, or the consumption of medicine that affects blood lipid level (e.g. OCP, corticosteroid, etc.); special illnesses that affect lipid profile (e.g. renal failure); discontinuing treatment at any stage; smoking, drug and alcohol abuse; taking medicine or doing anything that affects lipid profile 30 days prior to the study; any side effect that might stop treatment and major stress levels based on DSM IV during the study or the last three months.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum Low Density Lipoprotein- Cholestrol Level. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Serum High Density Lipoprotein- Cholesterol Level. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Serum Total Cholesterol Level. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Serum Triglyceride Level. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Added at 2017-11-18: Apptetite. Timepoint: Added at 2017-11-18: Before intervention and at the end of study. Method of measurement: Added at 2017-11-18: VAS questionnaire.

Secondary Outcome Measures

Name	Time	Method
Serum Glutamic Pyruvic Teransamins. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Serum Glutamic Oxaloacetic Transaminase. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Fasting Blood Suger. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Serum Blood Urea Nitrogen Level. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Serum Creatinine Level. Timepoint: Before the intervention, the end of the 4th & 8th week intervention. Method of measurement: Blood sample.;Added at 2017-11-18: Sleep disorders. Timepoint: Added at 2017-11-18: Before intervention and at the end of study. Method of measurement: Added at 2017-11-18: Sleep questionnaire.